ZANOSAR 1 g, powder for concentrate for infusion bottle, 1 g
Active ingredients: STREPTOZOCINE
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for concentrate for infusionbottle, 1 gintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZANOSAR 1 g, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon en verre de 1 g
- Marketing authorisation holder
- ESTEVE PHARMACEUTICALS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Feb 2019
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63371175CIP75505580CIP133400955055808Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| STREPTOZOCINEpoudre | 1 g · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.